tumor molecular profiling
Showing 9951 - 9975 of >10,000
Advanced Solid Tumor Trial in Philadelphia (Low dose radiation and ALA)
Recruiting
- Advanced Solid Tumor
- Low dose radiation and ALA
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 18, 2022
HER2 Positive Gastric Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (FATE-NK100,
Completed
- HER2 Positive Gastric Cancer
- +10 more
- FATE-NK100
- +2 more
-
San Diego, California
- +3 more
Nov 18, 2021
Solid Tumor, Adult Trial in Seoul (TAS-117)
Completed
- Solid Tumor, Adult
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Apr 21, 2021
Follicular Lymphoma Trial in Newnan (Oncoquest-L vaccine)
Not yet recruiting
- Follicular Lymphoma
- Oncoquest-L vaccine
-
Newnan, GeorgiaSoutheastern Regional Medical Center at CTCA
Apr 7, 2021
NCI Pediatric Oncology Branch Research Study
Completed
- Ewing Sarcoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 7, 2020
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 11, 2022
Targeted Axillary Dissection After Neo-adjuvant Chemotherapy
Recruiting
- Breast Cancer
- TAD (Targeted Axillary Dissection)
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Aug 12, 2022
Breast Cancer Female, Chemo Effect Trial in Milano (MAMMOT2)
Recruiting
- Breast Cancer Female
- Chemotherapy Effect
- MAMMOT2
-
Milano, ItalyOspedale San Raffaele
Feb 22, 2021
Low Back Pain, Modic Changes Type I or II Seen on MRI Trial in Oslo (Amoxicillin (Amoksicillintrihydrat), Placebo)
Completed
- Low Back Pain
- Modic Changes Type I or II Seen on MRI
- Amoxicillin (Amoksicillintrihydrat)
- Placebo
-
Oslo, NorwayOslo University Hospital Ullevål
Sep 21, 2021
Glioblastoma Trial in Mannheim (gamma knife radiosurgery (15 Gy to 50% isodose))
Active, not recruiting
- Glioblastoma
- gamma knife radiosurgery (15 Gy to 50% isodose)
-
Mannheim, GermanyDepartment of Radiotherapy University Hospital Mannheim
Apr 27, 2021
Natural History of Idiopathic CD4+ Lymphocytopenia
Recruiting
- Idiopathic CD4+ Lymphocytopenia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Mental Disorders, Psychosocial Distress and Care Needs of
Recruiting
- Neoplasm Malignant
-
Leipzig, Saxony, GermanyDepartment of Medical Psychology and Medical Sociology, Universi
May 17, 2022
Personalised Medicine for Morbid Obesity
Suspended
- Diabetes
-
London, United KingdomImperial Weight Centre
Feb 15, 2021
Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Anti-CD19 and anti-CD20 bicistronic CAR T- cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Liver Cirrhosis Trial in New Delhi (Carvedilol, Standard Medical Treatment)
Recruiting
- Liver Cirrhosis
- Carvedilol
- Standard Medical Treatment
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Oct 21, 2021
Submucosal Tumor of Stomach Trial in Hamburg (removal of submucosal gastric tumor preferably by Full Thickness Resection Device
Recruiting
- Submucosal Tumor of Stomach
- removal of submucosal gastric tumor preferably by Full Thickness Resection Device (FTRD)
-
Hamburg, GermanyUniversity Hospital Hamburg Eppendorf
Jun 20, 2021
Low Risk Differentiated Thyroid Cancer Trial in Villejuif (rhTSH stimulation, I131, Follow up)
Active, not recruiting
- Low Risk Differentiated Thyroid Cancer
- rhTSH stimulation
- +2 more
-
Villejuif, Val De Marne, FranceInstitut Gustave Roussy
Dec 7, 2021
Metastatic Breast Cancer Trial in United States (biomarker study)
Completed
- Metastatic Breast Cancer
- biomarker study
-
Birmingham, Alabama
- +7 more
Jun 30, 2020
Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)
Recruiting
- Radiotherapy
- +3 more
- Radiotherapy plus Toripalimab
- Sorafenib
-
Beijing, Beijing, ChinaBo Chen
Mar 6, 2021
Nasopharyngeal Carcinoma, Nutritional Support Trial in China (dietary supplement, radiation, drug)
Recruiting
- Nasopharyngeal Carcinoma
- Nutritional Support
- Abbott®Ensure
- +2 more
-
Fuzhou, Fujian, China
- +12 more
May 16, 2022
Primary Brain Tumor Patients
Completed
- Brain Tumor
- Cognitive Surveys
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 30, 2020
Differential Leucocyte Count and Covid-19 Diagnosis
Withdrawn
- SARS-CoV-2 Infection Covid19
- Differential Leucocyte Count (CLDC) device and algorithm
-
Pozzilli, IS, ItalyIRCCS INM Neuromed, Department of Epidemiology and Prevention
Jan 11, 2022
Leukemia, Lymphoblastic (Acute) Trial in Houston (MultiTAA-specific T cells)
Active, not recruiting
- Leukemia, Lymphoblastic (Acute)
- MultiTAA-specific T cells
-
Houston, Texas
- +1 more
Aug 6, 2021